EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Medication Knowledge of Patients with Parkinson's Disease: Strengths and Gaps

Stephan Greten iD, Sarana Ulaganathan, Johannes Heck, Lan Ye, Matthias Höllerhage, Christoph Schrader, Corinna Ziemann, Olaf Krause, Florian Wegner, Martin Klietz iD

Movement Disorders Clinical Practice · 2026-06 · 13 (6) · 1427-1434

DOI: 10.1002/mdc3.70466 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Movement Disorders Clinical Practice, online erschienen am 09.12.2025. Verfasst von Stephan Greten und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Hannover Medical School, Hannover, Germany. Hauptthemen laut MEDLINE: Parkinson Disease, Health Knowledge, Attitudes, Practice, Antiparkinson Agents, Medication Adherence. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Deutsche Gesellschaft für Parkinson und Bewegungsstörungen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Effective drug treatment of motor and non‐motor symptoms in Parkinson's disease (PD) often requires the administration of several anti‐Parkinson drugs in complex treatment regimens. The successful autonomous application of drugs places high demands on therapy adherence, which in turn relies on sufficient medication knowledge. However, limited information exists regarding the medication knowledge among PD patients.

Objectives

The aim of this study was to determine the knowledge of PD patients regarding drug treatment, device‐aided therapies and to explore potential factors influencing this knowledge.

Methods

The study was conducted as a prospective, cross‐sectional, interview‐based investigation, enrolling 70 patients. Knowledge on medication was standardized according to the number of drugs taken and expressed as a medication knowledge quotient (MKQ).

Results

The median MKQ was reasonably high at 4.9 (IQR 3.5–5.9), without influence of sex and disease duration. Increasing age ( p = 0.003), decreasing cognitive function ( p < 0.001), low educational attainment ( p < 0.001) and dispensing responsibility for drug provision ( p < 0.001) negatively influenced MKQ. Knowledge regarding anti‐Parkinson's drugs (ATC N04) was significantly higher than knowledge of other drug classes ( p < 0.001). In contrast, knowledge of device‐aided treatment options was poor.

Conclusion

PD patients displayed a high level of medication knowledge, particularly regarding anti‐Parkinson's drugs. Age and the accompanying cognitive impairment had a negative impact on medication knowledge. By contrast, knowledge of the key features of device‐aided treatment options requires considerable improvement.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseHealth Knowledge, Attitudes, PracticeAntiparkinson AgentsMedication AdherenceHumansFemaleMaleAgedCross-Sectional StudiesMiddle AgedProspective Studies

Stichwörter der Autor:innen

Parkinson's diseaseadherencedevice‐aided treatment optionsmedication knowledge

Substanzen

Antiparkinson Agents

Autor:innen und Institutionen

  • Department of Neurology, Hannover Medical School, Hannover, Germany.
  • Institute for Clinical Pharmacology, Hannover Medical School, Hannover, Germany.
  • Center for Medicine of the Elderly, DIAKOVERE Henriettenstift and Department of General Medicine and Palliative Care, Hannover Medical School, Hannover, Germany.
  • Hospital DIAKOVERE Henriettenstift, Center for Geriatric Medicine, Hannover, Germany.

ORCID-Profile: Stephan Greten, Martin Klietz

Förderung

  • Deutsche Forschungsgemeinschaft
  • Deutsche Gesellschaft für Parkinson und Bewegungsstörungen

Zitieren

APA

Greten, S., Ulaganathan, S., Heck, J., Ye, L., Höllerhage, M., Schrader, C., Ziemann, C., Krause, O., Wegner, F., & Klietz, M. (2026). Medication Knowledge of Patients with Parkinson's Disease: Strengths and Gaps. Movement Disorders Clinical Practice, 13(6), 1427-1434. https://doi.org/10.1002/mdc3.70466

Vancouver

Greten S, Ulaganathan S, Heck J, Ye L, Höllerhage M, Schrader C, et al. Medication Knowledge of Patients with Parkinson's Disease: Strengths and Gaps. Movement Disorders Clinical Practice. 2026;13(6):1427-1434. doi:10.1002/mdc3.70466

BibTeX
@article{Greten2026,
  author = {Greten, Stephan and Ulaganathan, Sarana and Heck, Johannes and Ye, Lan and Höllerhage, Matthias and Schrader, Christoph and Ziemann, Corinna and Krause, Olaf and Wegner, Florian and Klietz, Martin},
  title = {Medication Knowledge of Patients with Parkinson's Disease: Strengths and Gaps},
  journal = {Movement Disorders Clinical Practice},
  year = {2026},
  volume = {13},
  number = {6},
  pages = {1427--1434},
  doi = {10.1002/mdc3.70466}
}
Kostenlos starten →